Drawing for EMZENT

USPTO serial 87746779

EMZENT

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
CHISOLM, KEVON
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with EMZENT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Maury M. Tepper, III

Maury M. Tepper, III TEPPER & EYSTER PLLC3724 BENSON DRIVERALEIGH, NC 27609UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations acting on the central nervous system, namely, pharmaceutical preparations for the treatment of multiple sclerosis; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the musculo-skeletal system and the genitourinary system, namely, multiple sclerosis; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders, namely, multiple sclerosisACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jun 22, 2020MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jun 22, 2020ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Nov 20, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 18, 2019EX1GSOU EXTENSION 1 GRANTED—
Nov 18, 2019EXT1SOU EXTENSION 1 FILED—
Nov 18, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 21, 2019NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 10, 2019TMBNTTAB RELEASE CASE TO TRADEMARKS—
Apr 10, 2019OP.TOPPOSITION TERMINATED NO. 999999—
Apr 10, 2019OP.DOPPOSITION DISMISSED NO. 999999—
Oct 1, 2018OP.IOPPOSITION INSTITUTED NO. 999999—
May 1, 2018ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Apr 3, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 3, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 14, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 27, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 26, 2018DOCKASSIGNED TO EXAMINER—
Jan 22, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 11, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance